Treatment of Advanced Squamous-Cell Carcinoma of the Trachea When Radical Treatment Is Not an Option

Squamous cell carcinoma is the predominant histology of primary tracheal carcinomas, typically seen in older men with a smoking history. When the disease is advanced and the patient is not a candidate for radical treatment — whether due to extent of disease or patient fitness — the therapeutic focus shifts to systemic options.

For patients not eligible for radical intervention, a palliative systemic strategy is pursued. When standard options have been exhausted, molecular profiling plays a key role: next-generation sequencing (NGS) can be used to identify actionable genetic alterations and guide selection of targeted agents in an off-label setting.

The full protocol details — including sequencing, specific agent selection criteria, and decision points — are available via the structured regimen.